Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 161 Leukemia 98 Lymphoma, Large B-Cell, Diffuse 94 Precursor Cell Lymphoblastic Leukemia-Lymphoma 91 Lymphoma, Non-Hodgkin 91 Leukemia, Myeloid, Acute 74 Hodgkin Disease 73 Lymphoma, Follicular 63 Burkitt Lymphoma 59 Lymphoma, Mantle-Cell 56 Lymphoma, Large-Cell, Immunoblastic 55 Small Cell Lung Carcinoma 46 Leukemia, Lymphocytic, Chronic, B-Cell 42 Lung Neoplasms 41 Neuroblastoma 40 Lymphoma, B-Cell, Marginal Zone 33 Congenital Abnormalities 32 Multiple Myeloma 30 Recurrence 27 Sarcoma 26 Central Nervous System Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Leukemia, Myelomonocytic, Acute 24 Leukemia, Monocytic, Acute 24 Leukemia, Erythroblastic, Acute 24 Myelodysplastic Syndromes 23 Testicular Neoplasms 22 Lymphoma, Large-Cell, Anaplastic 22 Leukemia, Megakaryoblastic, Acute 22 Brain Neoplasms 22

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Etoposide × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡